Dubois-Stringfellow Nathalie 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Dubois-Stringfellow Nathalie（CIK 1947007）在 1 家公司共报告 11 笔 SEC Form 4 内部人交易（最近一笔 2026-05-27）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-05-27 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 4,036 | $686 |
| 2026-04-23 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 345,942 | $89,945 |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 2,063 | $970 |
| 2026-02-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 12,354 | $5,806 |
| 2026-01-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 36,676 | $14,670 |
| 2025-11-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 2,544 | $1,068 |
| 2025-10-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 43,741 | $28,869 |
| 2025-08-26 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 1,792 | $1,057 |
| 2025-07-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 31,866 | $15,296 |
| 2025-05-28 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 1,792 | $842 |
| 2025-04-24 | SANGAMO THERAPEUTICS, INC (SGMO) | SVP-CHIEF DEVELOPMENT OFFICER | 卖出 | 31,866 | $24,855 |
来源：SEC Form 4 申报文件 · 截至 2026-05-27